AURORA CANNABIS INC (ACB) Form 6-K — Oct 14, 2026

Aurora Cannabis' Board, on the unanimous recommendation of its Special Committee, reaffirmed its recommendation that shareholders REJECT Curaleaf's revised hostile bid for all outstanding Aurora shares, saying the offer significantly undervalues the debt-free company. The Board argues the revised consideration is inadequate per an updated fairness opinion, relies heavily on Curaleaf shares at an inflated valuation, and would in effect use Aurora's own balance-sheet cash to fund the takeover. The bid remains open until December 4, 2026.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.